Nrf2 as molecular target for polyphenols: A novel therapeutic strategy in diabetic retinopathy

Critical Reviews in Clinical Laboratory Sciences

Volumn 53, Issue 5, 2016, Pages 293-312

  Nabavi, Seyed Fazel ^a   Barber, Alistair J ^b   Spagnuolo, Carmela ^c   Russo, Gian Luigi ^c   Daglia, Maria ^d   Nabavi, Seyed Mohammad ^a   Sobarzo Sánchez, Eduardo ^e  

^a BAQIYATALLAH UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

^c CNR   (Italy)

^d UNIVERSITY OF PAVIA   (Italy)

^e UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

Author keywords

antioxidant response element; Diabetic retinopathy; Nrf2; polyphenols

Indexed keywords

CAFFEIC ACID; CURCUMIN; DJ 1 PROTEIN; ELLAGIC ACID; EPIGALLOCATECHIN GALLATE; GENISTEIN; GLUTATHIONE; HYDROXYL RADICAL; HYDROXYTYROSOL; LYCOPENE; MESSENGER RNA; OXYGEN; PEROXIDASE; PEROXIREDOXIN; PLANT MEDICINAL PRODUCT; POLYPHENOL; QUERCETIN; RESVERATROL; SUPEROXIDE; TRANSCRIPTION FACTOR NRF2; NFE2L2 PROTEIN, HUMAN;

ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ANTIOXIDANT RESPONSIVE ELEMENT; BINDING SITE; CELL PROTECTION; DIABETIC RETINOPATHY; DRUG TARGETING; ELECTROPHILIC STRESS; HUMAN; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RETINA GANGLION CELL; REVIEW; ANIMAL; DRUG DELIVERY SYSTEM; MOUSE; PROCEDURES;

ANIMALS; DIABETIC RETINOPATHY; DRUG DELIVERY SYSTEMS; HUMANS; MICE; NF-E2-RELATED FACTOR 2; POLYPHENOLS;

EID: 84961207101     PISSN: 10408363     EISSN: 1549781X     Source Type: Journal    
DOI: 10.3109/10408363.2015.1129530     Document Type: Review

References (253)

1. S.E.Kahn, R.L.Hull, K.M.Utzschneider Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature 2006;444:840–6
2. S.Zunino Type 2 diabetes and glycemic response to grapes or grape products. J Nutr 2009;139:1794S–800S
3. S.F.Nabavi, R.Thiagarajan, L.Rastrelli,. Curcumin: a natural product for diabetes and its complications. Curr Top Med Chem 2015;15:2445–55
4. J.R.GavinIII, K.Alberti, M.B.Davidson, R.A.DeFronzo Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 2001;24:S5
5. G.Imperatore, J.P.Boyle, T.J.Thompson,. Projections of type 1 and type 2 diabetes burden in the U.S. population aged <20 years through 2050: dynamic modeling of incidence, mortality, and population growth. Diabetes Care 2012;35:2515–20
6. T.L.Van Belle, K.T.Coppieters, M.G.Von Herrath Type 1 diabetes: etiology, immunology, and therapeutic strategies. Physiol Rev 2011;91:79–118
7. S.Kahn The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of type 2 diabetes. Diabetologia 2003;46:3–19
8. L.J.Scott, K.L.Mohlke, L.L.Bonnycastle,. A genome-wide association study of type 2 diabetes in Finns detects multiple susceptibility variants. Science 2007;316:1341–5
9. F.B.Hu Globalization of diabetes: the role of diet, lifestyle, and genes. Diabetes Care 2011;34:1249–57
10. J.E.Shaw, R.A.Sicree, P.Z.Zimmet Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract 2010;87:4–14
11. S.F.Nabavi, S.Habtemariam, M.Daglia,. Anthocyanins as a potential therapy for diabetic retinopathy. Curr Med Chem 2015;22:51–8
12. W.T.Driskill Diabetes continues to the nation’s fourth leading cause of death. Health Edu 1996;12:18–23
13. G.L.King, M.Kunisaki, Y.Nishio,. Biochemical and molecular mechanisms in the development of diabetic vascular complications. Diabetes 1996;45:S105–S8
14. F.Giacco, M.Brownlee Oxidative stress and diabetic complications. Circ Res 2010;107:1058–70
15. M.J.Fowler Microvascular and macrovascular complications of diabetes. Clin Diabetes 2008;26:77–82
16. T.Curtis, T.Gardiner, A.Stitt Microvascular lesions of diabetic retinopathy: clues towards understanding pathogenesis? Eye 2009;23:1496–508
17. Q.Mohamed, M.C.Gillies, T.Y.Wong Management of diabetic retinopathy: a systematic review. JAMA 2007;298:902–16
18. T.Nagaoka, A.Yoshida Relationship between retinal blood flow and renal function in patients with type 2 diabetes and chronic kidney disease. Diabetes Care 2013;36:957–61
19. H.Izzedine, B.Bodaghi, V.Launay-Vacher, G.Deray Eye and kidney: from clinical findings to genetic explanations. J Am Soc Nephrol 2003;14:516–29
20. I.Russell-Eggitt, D.Bockenhauer The blind kidney: disorders affecting kidneys and eyes. Pediatr Nephrol 2013;28:2255–65
21. T.Evans, D.X.Deng, S.Chen, S.Chakrabarti Endothelin receptor blockade prevents augmented extracellular matrix component mRNA expression and capillary basement membrane thickening in the retina of diabetic and galactose-fed rats. Diabetes 2000;49:662–6
22. E.C.Carlson Scanning and transmission electron microscopic studies of normal and diabetic acellular glomerular and retinal microvessel basement membranes. Microsc Res Tech 1994;28:165–77
23. P.Goodwin Management of diabetic retinopathy: a systematic review. Evid Based Ophthalmol 2008;9:36–7
24. T.W.Gardner, D.A.Antonetti, A.J.Barber,. Group PSRR. Diabetic retinopathy: more than meets the eye. Surv Ophthalmol 2002;47:S253–S62
25. A.M.Joussen, V.Poulaki, M.L.Le,. A central role for inflammation in the pathogenesis of diabetic retinopathy. FASEB J 2004;18:1450–2
26. F.Pfister, Y.Feng, F.vom Hagen,. Pericyte migration: a novel mechanism of pericyte loss in experimental diabetic retinopathy. Diabetes 2008;57:2495–502
27. J.W.Yau, S.L.Rogers, R.Kawasaki,. Global prevalence and major risk factors of diabetic retinopathy. Diabetes Care 2012;35:556–64
28. T.N.Crawford, I.Alfaro, J.B.Kerrison, E.P.Jablon Diabetic retinopathy and angiogenesis. Curr Diabetes Rev 2009;5:8–13
29. V.Patel, S.Rassam, R.Newsom,. Retinal blood flow in diabetic retinopathy. BMJ 1992;305:678–83
30. F.L.Ferris, A.Patz Macular edema. A complication of diabetic retinopathy. Surv Ophthalmol 1984;28:452–61
31. R.A.Kowluru, P.S.Chan Oxidative stress and diabetic retinopathy. Exp Diabetes Res 2007;2007:43603
32. A.J.Barber, T.W.Gardner, S.F.Abcouwer The significance of vascular and neural apoptosis to the pathology of diabetic retinopathy. Invest Ophthalmol Vis Sci 2011;52:1156–63
33. S.Sivaprasad, B.Gupta, R.Crosby-Nwaobi, J.Evans Prevalence of diabetic retinopathy in various ethnic groups: a worldwide perspective. Surv Ophthalmol 2012;57:347–70
34. R.J.Tapp, J.E.Shaw, C.A.Harper,. The prevalence of and factors associated with diabetic retinopathy in the Australian population. Diabetes Care 2003;26:1731–7
35. D.S.Fong, L.Aiello, T.W.Gardner,. Retinopathy in diabetes. Diabetes Care 2004;27:s84–s7
36. G.A.Williams, I.U.Scott, J.A.Haller,. Single-field fundus photography for diabetic retinopathy screening: a report by the American Academy of Ophthalmology. Ophthalmology 2004;111:1055–62
37. W.Goebel, T.Kretzchmar-Gross Retinal thickness in diabetic retinopathy: a study using optical coherence tomography (OCT). Retina 2002;22:759–67
38. M.D.Abràmoff, M.Niemeijer, M.S.Suttorp-Schulten,. Evaluation of a system for automatic detection of diabetic retinopathy from color fundus photographs in a large population of patients with diabetes. Diabetes Care 2008;31:193–8
39. S.C.Oliver, S.D.Schwartz, editors. Peripheral Vessel Leakage (PVL): A New Angiographic Finding in Diabetic Retinopathy Identified with Ultra Wide-Field Fluorescein Angiography. Seminars in Ophthalmology; 2010: London: Informa UK Ltd
40. A.N.Kollias, M.W.Ulbig Diabetic retinopathy: early diagnosis and effective treatment. Dtsch Arztebl Int 2010;107:75–83
41. H.Helbig Surgery for diabetic retinopathy. Ophthalmologica 2006;221:103–11
42. R.Simó, C.Hernández Intravitreous anti-VEGF for diabetic retinopathy: hopes and fears for a new therapeutic strategy. Diabetologia 2008;51:1574–80
43. D.S.Fong, A.Girach, A.Boney Visual side effects of successful scatter laser photocoagulation surgery for proliferative diabetic retinopathy: a literature review. Retina 2007;27:816–24
44. D.Yorston, L.Wickham, S.Benson,. Predictive clinical features and outcomes of vitrectomy for proliferative diabetic retinopathy. Br J Ophthalmol 2008;92:365–8
45. R.Simó, C.Hernandez Advances in the medical treatment of diabetic retinopathy. Diabetes Care 2009;32:1556–62
46. R.E.Anderson, L.M.Rapp, R.D.Wiegand Lipid peroxidation and retinal degeneration. Curr Eye Res 1984;3:223–7
47. A.Catala Lipid peroxidation of membrane phospholipids in the vertebrate retina. Front Biosci (Schol Ed) 2010;3:52–60
48. F.Van Kuijk, P.Buck Fatty acid composition of the human macula and peripheral retina. Invest Ophthalmol Vis Sci 1992;33:3493–6
49. M.S.Ola, M.I.Nawaz, M.M.Siddiquei,. Recent advances in understanding the biochemical and molecular mechanism of diabetic retinopathy. J Diabetes Complications 2012;26:56–64
50. M.Brownlee Biochemistry and molecular cell biology of diabetic complications. Nature 2001;414:813–20
51. M.J.Sheetz, G.L.King Molecular understanding of hyperglycemia’s adverse effects for diabetic complications. JAMA 2002;288:2579–88
52. G.L.King The role of inflammatory cytokines in diabetes and its complications. J Periodontol 2008;79:1527–34
53. R.A.Kowluru, R.L.Engerman, T.S.Kern Abnormalities of retinal metabolism in diabetes or experimental galactosemia. VI. Comparison of retinal and cerebral cortex metabolism, and effects of antioxidant therapy. Free Radic Biol Med 1999;26:371–8
54. R.A.Kowluru, J.Tang, T.S.Kern Abnormalities of retinal metabolism in diabetes and experimental galactosemia VII. Effect of long-term administration of antioxidants on the development of retinopathy. Diabetes 2001;50:1938–42
55. R.A.Kowluru, B.Menon, D.L.Gierhart Beneficial effect of zeaxanthin on retinal metabolic abnormalities in diabetic rats. Invest Ophthalmol Vis Sci 2008;49:1645–51
56. R.A.Kowluru Effect of reinstitution of good glycemic control on retinal oxidative stress and nitrative stress in diabetic rats. Diabetes 2003;52:818–23
57. M.Kanwar, P.-S.Chan, T.S.Kern, R.A.Kowluru Oxidative damage in the retinal mitochondria of diabetic mice: possible protection by superoxide dismutase. Invest Ophthalmol Vis Sci 2007;48:3805–11
58. T.M.Paravicini, R.M.Touyz NADPH oxidases, reactive oxygen species, and hypertension clinical implications and therapeutic possibilities. Diabetes Care 2008;31:S170–S80
59. M.Sedeek, A.C.Montezano, R.L.Hebert,. Oxidative stress, Nox isoforms and complications of diabetes-potential targets for novel therapies. J Cardiovasc Transl Res 2012;5:509–18
60. A.W.Stitt, A.J.Jenkins, M.E.Cooper Advanced glycation end products and diabetic complications. Expert Opin Investig Drugs 2002;11:1205–23
61. S.Z.Safi, R.Qvist, S.Kumar,. Molecular mechanisms of diabetic retinopathy, general preventive strategies, and novel therapeutic targets. BioMed Res Int 2014;2014:801269
62. S.E.Jeganathan The therapeutic implications of renin-angiotensin system blockade in diabetic retinopathy. Curr Pharm Biotechnol 2011;12:392–5
63. J.L.Wilkinson-Berka, I.Rana, R.Armani, A.Agrotis Reactive oxygen species, Nox and angiotensin II in angiogenesis: implications for retinopathy. Clin Sci 2013;124:597–615
64. Q.Zhong, M.Mishra, R.A.Kowluru Transcription factor Nrf2-mediated antioxidant defense system in the development of diabetic retinopathy. Invest Ophthalmol Vis Sci 2013;54:3941–8
65. Z.Xu, Y.Wei, J.Gong,. NRF2 plays a protective role in diabetic retinopathy in mice. Diabetologia 2014;57:204–13
66. R.A.Kowluru, S.N.Abbas Diabetes-induced mitochondrial dysfunction in the retina. Invest Ophthalmol Vis Sci 2003;44:5327–34
67. Y.Du, C.M.Miller, T.Kern Hyperglycemia increases mitochondrial superoxide in retina and retinal cells. Free Radic Biol Med 2003;35:1491–9
68. Y.Cui, X.Xu, H.Bi,. Expression modification of uncoupling proteins and MnSOD in retinal endothelial cells and pericytes induced by high glucose: the role of reactive oxygen species in diabetic retinopathy. Exp Eye Res 2006;83:807–16
69. E.A.Ellis, D.L.Guberski, M.Somogyi-Mann, M.B.Grant Increased H2O2, vascular endothelial growth factor and receptors in the retina of the BBZ/Wor diabetic rat. Free Radic Biol Med 2000;28:91–101
70. K.Haskins, B.Bradley, K.Powers,. Oxidative stress in type 1 diabetes. Ann NY Acad Sci 2003;1005:43–54
71. E.S.Ford, A.H.Mokdad, W.H.Giles, D.W.Brown The metabolic syndrome and antioxidant concentrations findings from the Third National Health and Nutrition Examination Survey. Diabetes 2003;52:2346–52
72. A.Meister Glutathione metabolism and its selective modification. J Biol Chem 1988;263:17205–8
73. R.Kowluru Diabetes-induced elevations in retinal oxidative stress, protein kinase C and nitric oxide are interrelated. Acta Diabetol 2001;38:179–85
74. S.Kubota, T.Kurihara, H.Mochimaru,. Prevention of ocular inflammation in endotoxin-induced uveitis with resveratrol by inhibiting oxidative damage and Nuclear factor-kappaB activation. Invest Ophthalmol Vis Sci 2009;50:3512–19
75. T.S.Kern Contributions of inflammatory processes to the development of the early stages of diabetic retinopathy. Exp Diabetes Res 2007;2007:95103
76. S.Ejaz, I.Chekarova, A.Ejaz,. Importance of pericytes and mechanisms of pericyte loss during diabetes retinopathy. Diabetes Obes Metab 2008;10:53–63
77. S.Yatoh, M.Mizutani, T.Yokoo,. Antioxidants and an inhibitor of advanced glycation ameliorate death of retinal microvascular cells in diabetic retinopathy. Diabetes Metab Res Rev 2006;22:38–45
78. R.Mancino, D.Di Pierro, C.Varesi,. Lipid peroxidation and total antioxidant capacity in vitreous, aqueous humor, and blood samples from patients with diabetic retinopathy. Mol Vis 2011;17:1298–304
79. S.F.Nabavi, S.M.Nabavi, W.N Setzer,. Antioxidant and antihemolytic activity of lipid-soluble bioactive substances in avocado fruits. Fruits 2013;68:185–93
80. S.F.Nabavi, S.M.Nabavi, M.A.Ebrahimzadeh,. In vitro antioxidant and antihemolytic activities of hydroalcoholic extracts of Allium scabriscapum Boiss. & Ky. aerial parts and bulbs. Int J Food Prop 2013;16:713–22
81. H.Alinezhad, R.Azimi, M.Zare,. Antioxidant and antihemolytic activities of ethanolic extract of flowers, leaves, and stems of Hyssopus officinalis L. Var. angustifolius. Int J Food Prop 2013;16:1169–78
82. S.F.Nabavi, S.M.Nabavi, S.Habtemariam,. Hepatoprotective effect of gallic acid isolated from Peltiphyllum peltatum against sodium fluoride-induced oxidative stress. Ind Crops Prod 2013;44:50–5
83. A.J.Kowaltowski, N.C.de Souza-Pinto, R.F.Castilho, A.E.Vercesi Mitochondria and reactive oxygen species. Free Radic Biol Med 2009;47:333–43
84. W.Davis, Z.Ronai, K.D.Tew Cellular thiols and reactive oxygen species in drug-induced apoptosis. J Pharmacol Exp Ther 2001;296:1–6
85. J.N.Meyer, M.C.Leung, J.P.Rooney,. Mitochondria as a target of environmental toxicants. Toxicol Sci 2013;134:1–17
86. B.Halliwell Free radicals and antioxidants – quo vadis? Trends Pharmacol Sci 2011;32:125–30
87. H.Li, S.Horke, U.Förstermann Oxidative stress in vascular disease and its pharmacological prevention. Trends Pharmacol Sci 2013;34:313–19
88. J.M.Matés, J.A.Segura, F.J.Alonso, J.Márquez Oxidative stress in apoptosis and cancer: an update. Arch Toxicol 2012;86:1649–65
89. A.Federico, E.Cardaioli, P.Da Pozzo,. Mitochondria, oxidative stress and neurodegeneration. J Neurol Sci 2012;322:254–62
90. J.L.Rains, S.K.Jain Oxidative stress, insulin signaling, and diabetes. Free Radic Biol Med 2011;50:567–75
91. Y.-J.Surh, J.K.Kundu, H.-K.Na Nrf2 as a master redox switch in turning on the cellular signaling involved in the induction of cytoprotective genes by some chemopreventive phytochemicals. Planta Med 2008;74:1526–39
92. H.Motohashi, M.Yamamoto Nrf2-Keap1 defines a physiologically important stress response mechanism. Trends Mol Med 2004;10:549–57
93. M.J.Calkins, D.A.Johnson, J.A.Townsend,. The Nrf2/ARE pathway as a potential therapeutic target in neurodegenerative disease. Antioxid Redox Signal 2009;11:497–508
94. K.Itoh, T.Chiba, S.Takahashi,. An Nrf2/small Maf heterodimer mediates the induction of phase II detoxifying enzyme genes through antioxidant response elements. Biochem Biophysic Res Commun 1997;236:313–22
95. A.Kobayashi, M.-I.Kang, H.Okawa,. Oxidative stress sensor Keap1 functions as an adaptor for Cul3-based E3 ligase to regulate proteasomal degradation of Nrf2. Mol Cell Biol 2004;24:7130–9
96. Q.Ma, X.He Molecular basis of electrophilic and oxidative defense: promises and perils of Nrf2. Pharmacol Rev 2012;64:1055–81
97. H.E.de Vries, M.Witte, D.Hondius,. Nrf2-induced antioxidant protection: a promising target to counteract ROS-mediated damage in neurodegenerative disease? Free Radic Biol Med 2008;45:1375–83
98. K.Itoh, M.Mochizuki, Y.Ishii,. Transcription factor Nrf2 regulates inflammation by mediating the effect of 15-deoxy-Delta(12,14)-prostaglandin j(2). Mol Cell Biol 2004;24:36–45
99. D.D.Zhang, M.Hannink Distinct cysteine residues in Keap1 are required for Keap1-dependent ubiquitination of Nrf2 and for stabilization of Nrf2 by chemopreventive agents and oxidative stress. Mol Cell Biol 2003;23:8137–51
100. H.-C.Huang, T.Nguyen, C.B.Pickett Phosphorylation of Nrf2 at Ser-40 by protein kinase C regulates antioxidant response element-mediated transcription. J Biol Chem 2002;277:42769–74
101. C.M.Clements, R.S.McNally, B.J.Conti,. DJ-1, a cancer-and Parkinson’s disease-associated protein, stabilizes the antioxidant transcriptional master regulator Nrf2. Proc Natl Acad Sci USA 2006;103:15091–6
102. M.S.Bitar, C.Liu, A.Ziaei,. Decline in DJ-1 and decreased nuclear translocation of Nrf2 in Fuchs endothelial corneal dystrophy. Invest Ophthalmol Vis Sci 2012;53:5806–13
103. C.Liu, Y.Chen, I.E.Kochevar, U.V.Jurkunas Decreased DJ-1 leads to impaired Nrf2-regulated antioxidant defense and increased UV-A-induced apoptosis in corneal endothelial cells. Invest Ophthalmol Vis Sci 2014;55:5551–60
104. A.L.Eggler, K.A.Gay, A.D.Mesecar Molecular mechanisms of natural products in chemoprevention: induction of cytoprotective enzymes by Nrf2. Mol Nutr Food Res 2008;52:S84–94
105. W.-S.Jeong, M.Jun, A.-N.T.Kong Nrf2: a potential molecular target for cancer chemoprevention by natural compounds. Antioxid Redox Signal 2006;8:99–106
106. J.S.Lee, Y.J.Surh Nrf2 as a novel molecular target for chemoprevention. Cancer Lett 2005;224:171–84
107. F.Johnson, C.Giulivi Superoxide dismutases and their impact upon human health. Mol Aspects Med 2005;26:340–52
108. R.V.Lloyd, P.M.Hanna, R.P.Mason The origin of the hydroxyl radical oxygen in the Fenton reaction. Free Radic Biol Med 1997;22:885–8
109. Z.A.Wood, L.B.Poole, P.A.Karplus Peroxiredoxin evolution and the regulation of hydrogen peroxide signaling. Science 2003;300:650–3
110. G.F.Gaetani, S.Galiano, L.Canepa,. Catalase and glutathione peroxidase are equally active in detoxification of hydrogen peroxide in human erythrocytes. Blood 1989;73:334–9
111. M.Trujillo, G.Ferrer-Sueta, L.Thomson,. Kinetics of Peroxiredoxins and Their Role in the Decomposition of Peroxynitrite. Springer: Peroxiredoxin Systems; 2007:83–113
112. S.Sassa Why heme needs to be degraded to iron, biliverdin IXalpha, and carbon monoxide? Antioxid Redox Signal 2004;6:819–24
113. R.Gozzelino, V.Jeney, M.P.Soares Mechanisms of cell protection by heme oxygenase-1. Annu Rev Pharmacol Toxicol 2010;50:323–54
114. D.Siegel, D.L.Gustafson, D.L.Dehn,. NAD(P)H:quinone oxidoreductase 1: role as a superoxide scavenger. Mol Pharmacol 2004;65:1238–47
115. A.K.Raina, D.J.Templeton, J.C.Deak,. Quinone reductase (NQO1), a sensitive redox indicator, is increased in Alzheimer’s disease. Redox Rep 1999;4:23–7
116. P.M.Kidd Glutathione: systemic protectant against oxidative and free radical damage. Altern Med Rev 1997;2:155–76
117. J.B.Schulz, J.Lindenau, J.Seyfried, J.Dichgans Glutathione, oxidative stress and neurodegeneration. Eur J Biochem 2000;267:4904–11
118. J.D.Hayes, L.I.Mclellan Glutathione and glutathione-dependent enzymes represent a co-ordinately regulated defence against oxidative stress. Free Radic Res 1999;31:273–300
119. R.Kowluru, T.S.Kern, R.L.Engerman Abnormalities of retinal metabolism in diabetes or galactosemia. II. Comparison of gamma-glutamyl transpeptidase in retina and cerebral cortex, and effects of antioxidant therapy. Curr Eye Res 1994;13:891–6
120. M.A.Cotter, A.Love, M.J.Watt,. Effects of natural free radical scavengers on peripheral nerve and neurovascular function in diabetic rats. Diabetologia 1995;38:1285–94
121. R.A.Kowluru, T.S.Kern, R.L.Engerman, D.Armstrong Abnormalities of retinal metabolism in diabetes or experimental galactosemia. III. Effects of antioxidants. Diabetes 1996;45:1233–7
122. P.Maher, A.Hanneken Flavonoids protect retinal ganglion cells from oxidative stress-induced death. Invest Ophthalmol Vis Sci 2005;46:4796–803
123. N.Nagai, R.K.Thimmulappa, M.Cano,. Nrf2 is a critical modulator of the innate immune response in a model of uveitis. Free Radic Biol Med 2009;47:300–6
124. Y.Wei, J.Gong, T.Yoshida,. Nrf2 has a protective role against neuronal and capillary degeneration in retinal ischemia-reperfusion injury. Free Radic Biol Med 2011;51:216–24
125. A.J.Barber, E.Lieth, S.A.Khin,. Neural apoptosis in the retina during experimental and human diabetes. Early onset and effect of insulin. J Clin Invest 1998;102:783–91
126. A.J.Barber A new view of diabetic retinopathy: a neurodegenerative disease of the eye. Prog Neuropsychopharmacol Biol Psychiatry 2003;27:283–90
127. T.S.Kern, A.J.Barber Retinal ganglion cells in diabetes. J Physiol 2008;586:4401–8
128. M.J.Gastinger, R.S.Singh, A.J.Barber Loss of cholinergic and dopaminergic amacrine cells in streptozotocin-diabetic rat and ins2akita-diabetic mouse retinas. Invest Ophthalmol Vis Sci 2006;47:3143–50
129. A.Y.Shanab, T.Nakazawa, M.Ryu,. Metabolic stress response implicated in diabetic retinopathy: the role of calpain, and the therapeutic impact of calpain inhibitor. Neurobiol Dis 2012;48:556–67
130. J.Fan, G.Xu, T.Jiang, Y.Qin Pharmacologic induction of heme oxygenase-1 plays a protective role in diabetic retinopathy in rats. Invest Ophthalmol Vis Sci 2012;53:6541–56
131. M.Mishra, Q.Zhong, R.A.Kowluru Epigenetic modifications of Keap1 regulate its interaction with the protective factor Nrf2 in the development of diabetic retinopathy. Invest Ophthalmol Vis Sci 2014;55:7256–65
132. M.Mishra, Q.Zhong, R.A.Kowluru Epigenetic modifications of Nrf2-mediated glutamate-cysteine ligase: implications for the development of diabetic retinopathy and the metabolic memory phenomenon associated with its continued progression. Free Radic Biol Med 2014;75:129–39
133. A.J.Barber, D.A.Antonetti, T.S.Kern,. The Ins2Akita mouse as a model of early retinal complications in diabetes. Invest Ophthalmol Vis Sci 2005;46:2210–18
134. C.A.Lee, G.Li, M.D.Patel,. Diabetes-induced impairment in visual function in mice: contributions of p38 MAPK, rage, leukocytes, and aldose reductase. Invest Ophthalmol Vis Sci 2014;55:2904–10
135. M.H.Aung, H.N.Park, M.K.Han,. Dopamine deficiency contributes to early visual dysfunction in a rodent model of type 1 diabetes. J Neurosci 2014;34:726–36
136. M.H.Aung, M.K.Kim, D.E.Olson,. Early visual deficits in streptozotocin-induced diabetic long Evans rats. Invest Ophthalmol Vis Sci 2013;54:1370–7
137. N.P.Akimov, R.C.Renteria Spatial frequency threshold and contrast sensitivity of an optomotor behavior are impaired in the Ins2Akita mouse model of diabetes. Behav Brain Res 2012;226:601–5
138. X.Xu, P.Luo, Y.Wang,. Nuclear factor (erythroid-derived 2)-like 2 (NFE2L2) is a novel therapeutic target for diabetic complications. J Int Med Res 2013;41:13–19
139. D.Del Rio, A.Rodriguez-Mateos, J.P.Spencer,. Dietary (poly) phenolics in human health: structures, bioavailability, and evidence of protective effects against chronic diseases. Antioxid Redox Signal 2013;18:1818–92
140. R.H.Liu Health-promoting components of fruits and vegetables in the diet. Adv Nutr 2013;4:384S–92S
141. C.Manach, A.Scalbert, C.Morand,. Polyphenols: food sources and bioavailability. Am J Clin Nutr 2004;79:727–47
142. K.T.Turpaev Keap1-Nrf2 signaling pathway: mechanisms of regulation and role in protection of cells against toxicity caused by xenobiotics and electrophiles. Biochemistry 2013;78:111–26
143. N.K.Zenkov, E.B.Menshchikova, V.O.Tkachev Keap1/Nrf2/ARE redox-sensitive signaling system as a pharmacological target. Biochemistry 2013;78:19–36
144. S.F.Nabavi, M.Daglia, A.H.Moghaddam,. Curcumin and liver disease: from chemistry to medicine. Compre Rev Food Sci Food Safe 2014;13:62–77
145. A.T.Dinkova-Kostova, P.Talalay Relation of structure of curcumin analogs to their potencies as inducers of Phase 2 detoxification enzymes. Carcinogenesis 1999;20:911–14
146. S.Magesh, Y.Chen, L.Hu Small molecule modulators of Keap1-Nrf2-ARE pathway as potential preventive and therapeutic agents. Med Res Rev 2012;32:687–726
147. X.Zhang, D.Liang, L.Guo,. Curcumin protects renal tubular epithelial cells from high glucose-induced epithelial-to-mesenchymal transition through Nrf2-mediated upregulation of heme oxygenase-1. Mol Med Rep 2015;12:1347–55
148. S.González-Reyes, S.Guzmán-Beltrán, O.N.Medina-Campos, J.Pedraza-Chaverri Curcumin pretreatment induces Nrf2 and an antioxidant response and prevents hemin-induced toxicity in primary cultures of cerebellar granule neurons of rats. Oxid Med Cell Longev 2013;2013:801418
149. R.Zhao, B.Yang, L.Wang,. Curcumin protects human keratinocytes against inorganic arsenite-induced acute cytotoxicity through an NRF2-dependent mechanism. Oxid Med Cell Longev 2013;2013:412576
150. S.G.Zhao, Q.Li, Z.X.Liu,. Curcumin attenuates insulin resistance in hepatocytes by inducing Nrf2 nuclear translocation. Hepatogastroenterology 2011;58:2106–11
151. E.S.Kang, I.S.Woo, H.J.Kim,. Up-regulation of aldose reductase expression mediated by phosphatidylinositol 3-kinase/Akt and Nrf2 is involved in the protective effect of curcumin against oxidative damage. Free Radic Biol Med 2007;43:535–45
152. S.S.Boyanapalli, X.Paredes-Gonzalez, F.Fuentes,. Nrf2 knockout attenuates the anti-inflammatory effects of phenethyl isothiocyanate and curcumin. Chem Res Toxicol 2014;27:2036–43
153. C.Zeng, P.Zhong, Y.Zhao,. Curcumin protects hearts from FFA-induced injury by activating Nrf2 and inactivating NF-κB both in vitro and in vivo. J Mol Cell Cardiol 2015;79:1–12
154. B.Li, L.Wang, Q.Lu, W.Da Liver injury attenuation by curcumin in a rat NASH model: an Nrf2 activation-mediated effect? Ir J Med Sci 2014; doi:10.1007/s11845-014-1226-9
155. E.O.Farombi, S.Shrotriya, H.K.Na,. Curcumin attenuates dimethylnitrosamine-induced liver injury in rats through Nrf2-mediated induction of heme oxygenase-1. Food Chem Toxicol 2008;46:1279–87
156. J.Wu, Q.Li, X.Wang,. Neuroprotection by curcumin in ischemic brain injury involves the Akt/Nrf2 pathway. PLoS One 2013;8:e59843
157. C.Yang, X.Zhang, H.Fan, Y.Liu Curcumin upregulates transcription factor Nrf2, HO-1 expression and protects rat brains against focal ischemia. Brain Res 2009;1282:133–41
158. I.Carmona-Ramírez, A.Santamaría, J.C.Tobón-Velasco,. Curcumin restores Nrf2 levels and prevents quinolinic acid-induced neurotoxicity. J Nutr Biochem 2013;24:14–24
159. V.Soetikno, F.R.Sari, A.P.Lakshmanan,. Curcumin alleviates oxidative stress, inflammation, and renal fibrosis in remnant kidney through the Nrf2-keap1 pathway. Mol Nutr Food Res 2013;57:1649–59
160. E.Tapia, V.Soto, K.M.Ortiz-Vega,. Curcumin induces Nrf2 nuclear translocation and prevents glomerular hypertension, hyperfiltration, oxidant stress, and the decrease in antioxidant enzymes in 5/6 nephrectomized rats. Oxid Med Cell Longev 2012;2012:269039
161. H.Yang, W.Xu, Z.Zhou,. Curcumin attenuates urinary excretion of albumin in type ii diabetic patients with enhancing nuclear factor erythroid-derived 2-like 2 (nrf2) system and repressing inflammatory signaling efficacies. Exp Clin Endocrinol Diabetes 2015;123:360–7
162. R.P.Wu, T.Hayashi, H.B.Cottam,. Nrf2 responses and the therapeutic selectivity of electrophilic compounds in chronic lymphocytic leukemia. Proc Natl Acad Sci USA 2010;107:7479–84
163. J.A.Rubiolo, F.V.Vega Resveratrol protects primary rat hepatocytes against necrosis induced by reactive oxygen species. Biomed Pharmacother 2008;62:606–12
164. Z.Ungvari, Z.Bagi, A.Feher,. Resveratrol confers endothelial protection via activation of the antioxidant transcription factor Nrf2. Am J Physiol Heart Circ Physiol 2010;299:H18–24
165. A.E.Wagner, C.Boesch-Saadatmandi, D.Breckwoldt,. Ascorbic acid partly antagonizes resveratrol mediated heme oxygenase-1 but not paraoxonase-1 induction in cultured hepatocytes - role of the redox-regulated transcription factor Nrf2. BMC Complement Altern Med 2011;11:1
166. A.S.Cheng, Y.H.Cheng, C.H.Chiou, T.L.Chang Resveratrol upregulates Nrf2 expression to attenuate methylglyoxal-induced insulin resistance in Hep G2 cells. J Agric Food Chem 2012;60:9180–7
167. A.A.Javkhedkar, Y.Quiroz, B.Rodoriguez-Iturbe,. Resveratrol restored Nrf2 function, reduced renal inflammation and mitigated hypertension in spontaneously hypertensive rats. Am J Physiol Regul Integr Comp Physiol 2015;308:R840–6
168. P.Palsamy, S.Subramanian Resveratrol protects diabetic kidney by attenuating hyperglycemia-mediated oxidative stress and renal inflammatory cytokines via Nrf2-Keap1 signaling. Biochim Biophys Acta 2011;1812:719–31
169. E.Hao, F.Lang, Y.Chen,. Resveratrol alleviates endotoxin-induced myocardial toxicity via the Nrf2 transcription factor. PLoS One 2013;8:e69452
170. A.Kumar, C.K.Singh, H.A.Lavoie,. Resveratrol restores Nrf2 level and prevents ethanol-induced toxic effects in the cerebellum of a rodent model of fetal alcohol spectrum disorders. Mol Pharmacol 2011;80:446–57
171. J.Ren, C.Fan, N.Chen,. Resveratrol pretreatment attenuates cerebral ischemic injury by upregulating expression of transcription factor Nrf2 and HO-1 in rats. Neurochem Res 2011;36:2352–62
172. B.Singh, R.Shoulson, A.Chatterjee,. Resveratrol inhibits estrogen-induced breast carcinogenesis through induction of NRF2-mediated protective pathways. Carcinogenesis 2014;35:1872–80
173. S.M.Nabavi, S.F.Nabavi, S.Eslami, A.H.Moghaddam In vivo protective effects of quercetin against sodium fluoride-induced oxidative stress in the hepatic tissue. Food Chem 2012;132:931–5
174. S.F.Nabavi, G.L.Russo, M.Daglia, S.M.Nabavi Role of quercetin as an alternative for obesity treatment: you are what you eat! Food Chem 2015;179:305–10
175. S.F.Nabavi, S.M.Nabavi, M.Mirzaei, A.H.Moghaddam Protective effect of quercetin against sodium fluoride induced oxidative stress in rat’s heart. Food Funct 2012;3:437–41
176. M.Russo, C.Spagnuolo, I.Tedesco,. The flavonoid quercetin in disease prevention and therapy: facts and fancies. Biochem Pharmacol 2012;83:6–15
177. G.L.Russo, M.Russo, C.Spagnuolo,. Quercetin: a pleiotropic kinase inhibitor against cancer. Cancer Treat Res 2014;159:185–205
178. C.J.Weng, M.J.Chen, C.T.Yeh, G.C.Yen Hepatoprotection of quercetin against oxidative stress by induction of metallothionein expression through activating MAPK and PI3K pathways and enhancing Nrf2 DNA-binding activity. N Biotechnol 2011;28:767–77
179. A.B.Granado-Serrano, M.A.Martín, L.Bravo,. Quercetin modulates Nrf2 and glutathione-related defenses in HepG2 cells: involvement of p38. Chem Biol Interact 2012;195:154–64
180. S.Tanigawa, M.Fujii, D.X.Hou Action of Nrf2 and Keap1 in ARE-mediated NQO1 expression by quercetin. Free Radic Biol Med 2007;42:1690–703
181. C.L.Saw, Y.Guo, A.Y.Yang,. The berry constituents quercetin, kaempferol, and pterostilbene synergistically attenuate reactive oxygen species: involvement of the Nrf2-ARE signaling pathway. Food Chem Toxicol 2014;72:303–11
182. P.Yao, A.Nussler, L.Liu,. Quercetin protects human hepatocytes from ethanol-derived oxidative stress by inducing heme oxygenase-1 via the MAPK/Nrf2 pathways. J Hepatol 2007;47:253–61
183. P.Ramyaa, R.Krishnaswamy, V.V.Padma Quercetin modulates OTA-induced oxidative stress and redox signalling in HepG2 cells – upregulation of Nrf2 expression and down regulation of NF-κB and COX-2. Biochim Biophys Acta 2014;1840:681–92
184. P.Ramyaa, V.V.Padma Ochratoxin-induced toxicity, oxidative stress and apoptosis ameliorated by quercetin-modulation by Nrf2. Food Chem Toxicol 2013;62:205–16
185. L.L.Ji, Y.C.Sheng, Z.Y.Zheng,. The Involvement of p62-Keap1-Nrf2 antioxidative signaling pathway and JNK in the protection of natural flavonoid quercetin against hepatotoxicity. Free Radic Biol Med 2015;85:12–23
186. S.Kimura, E.Warabi, T.Yanagawa,. Essential role of Nrf2 in keratinocyte protection from UVA by quercetin. Biochem Biophys Res Commun 2009;387:109–14
187. N.Miyamoto, H.Izumi, R.Miyamoto,. Quercetin induces the expression of peroxiredoxins 3 and 5 via the Nrf2/NRF1 transcription pathway. Invest Ophthalmol Vis Sci 2011;52:1055–63
188. C.H.Kang, Y.H.Choi, S.K.Moon,. Quercetin inhibits lipopolysaccharide-induced nitric oxide production in BV2 microglial cells by suppressing the NF-κB pathway and activating the Nrf2-dependent HO-1 pathway. Int Immunopharmacol 2013;17:808–13
189. F.Arredondo, C.Echeverry, J.A.Abin-Carriquiry,. After cellular internalization, quercetin causes Nrf2 nuclear translocation, increases glutathione levels, and prevents neuronal death against an oxidative insult. Free Radic Biol Med 2010;49:738–47
190. J.Renaud, S.M.Nabavi, M.Daglia,. Epigallocatechin-3-gallate, a promising molecule for Parkinson’s disease? Rejuvenation Res 2015;18:257–69
191. H.H.Chow, I.A.Hakim Pharmacokinetic and chemoprevention studies on tea in humans. Pharmacol Res 2011;64:105–12
192. C.Chen, R.Yu, E.D.Owuor, A.N.Kong Activation of antioxidant-response element (ARE), mitogen-activated protein kinases (MAPKs) and caspases by major green tea polyphenol components during cell survival and death. Arch Pharm Res 2000;23:605–12
193. C.C.Wu, M.C.Hsu, C.W.Hsieh,. Upregulation of heme oxygenase-1 by epigallocatechin-3-gallate via the phosphatidylinositol 3-kinase/Akt and ERK pathways. Life Sci 2006;78:2889–97
194. H.K.Na, Y.J.Surh Modulation of Nrf2-mediated antioxidant and detoxifying enzyme induction by the green tea polyphenol EGCG. Food Chem Toxicol 2008;46:1271–8
195. J.Jiang, Z.C.Mo, K.Yin,. Epigallocatechin-3-gallate prevents TNF-α-induced NF-κB activation thereby upregulating ABCA1 via the Nrf2/Keap1 pathway in macrophage foam cells. Int J Mol Med 2012;29:946–56
196. Y.Wang, N.Liu, X.Su,. Epigallocatechin-3-gallate attenuates transforming growth factor-β1 induced epithelial-mesenchymal transition via Nrf2 regulation in renal tubular epithelial cells. Biomed Pharmacother 2015;70:260–7
197. H.S.Zhang, T.C.Wu, W.W.Sang, Z.Ruan EGCG inhibits Tat-induced LTR transactivation: role of Nrf2, AKT, AMPK signaling pathway. Life Sci 2012;90:747–54
198. S.G.Han, S.S.Han, M.Toborek, B.Hennig EGCG protects endothelial cells against PCB 126-induced inflammation through inhibition of AhR and induction of Nrf2-regulated genes. Toxicol Appl Pharmacol 2012;261:181–8
199. Z.M.Zhang, X.Y.Yang, J.H.Yuan,. Modulation of NRF2 and UGT1A expression by epigallocatechin-3-gallate in colon cancer cells and BALB/c mice. Chin Med J 2009;122:1660–5
200. S.Nair, A.Barve, T.O.Khor,. Regulation of Nrf2- and AP-1-mediated gene expression by epigallocatechin-3-gallate and sulforaphane in prostate of Nrf2-knockout or C57BL/6J mice and PC-3 AP-1 human prostate cancer cells. Acta Pharmacol Sin 2010;31:1223–40
201. P.Y.Tsai, S.M.Ka, J.M.Chang,. Epigallocatechin-3-gallate prevents lupus nephritis development in mice via enhancing the Nrf2 antioxidant pathway and inhibiting NLRP3 inflammasome activation. Free Radic Biol Med 2011;51:744–54
202. Y.Wang, B.Wang, F.Du,. Epigallocatechin-3-gallate attenuates oxidative stress and inflammation in obstructive nephropathy via NF-κB and Nrf2/HO-1 signalling pathway regulation. Basic Clin Pharmacol Toxicol 2015;117:164–72
203. T.Ye, J.Zhen, Y.Du,. Green tea polyphenol (-)-epigallocatechin-3-gallate restores nrf2 activity and ameliorates crescentic glomerulonephritis. PLoS One 2015;10:e0119543
204. K.Sahin, M.Tuzcu, H.Gencoglu,. Epigallocatechin-3-gallate activates Nrf2/HO-1 signaling pathway in cisplatin-induced nephrotoxicity in rats. Life Sci 2010;87:240–5
205. N.Sriram, S.Kalayarasan, G.Sudhandiran Epigallocatechin-3-gallate augments antioxidant activities and inhibits inflammation during bleomycin-induced experimental pulmonary fibrosis through Nrf2-Keap1 signaling. Pulm Pharmacol Ther 2009;22:221–36
206. G.Shen, C.Xu, R.Hu,. Comparison of (-)-epigallocatechin-3-gallate elicited liver and small intestine gene expression profiles between C57BL/6J mice and C57BL/6J/Nrf2 (−/−) mice. Pharm Res 2005;22:1805–20
207. D.Wang, Y.Wang, X.Wan,. Green tea polyphenol (-)-epigallocatechin-3-gallate triggered hepatotoxicity in mice: responses of major antioxidant enzymes and the Nrf2 rescue pathway. Toxicol Appl Pharmacol 2015;283:65–74
208. T.Erk, J.Hauser, G.Williamson,. Structure- and dose-absorption relationships of coffee polyphenols. Biofactors 2014;40:103–12
209. R.Sirota, D.Gibson, R.Kohen The role of the catecholic and the electrophilic moieties of caffeic acid in Nrf2/Keap1 pathway activation in ovarian carcinoma cell lines. Redox Biol 2015;4:48–59
210. X.Chao, X.He, Y.Yang,. Design, synthesis and pharmacological evaluation of novel tacrine-caffeic acid hybrids as multi-targeted compounds against Alzheimer’s disease. Bioorg Med Chem Lett 2012;22:6498–502
211. X.J.Chao, Z.W.Chen, A.M.Liu,. Effect of tacrine-3-caffeic acid, a novel multifunctional anti-Alzheimer’s dimer, against oxidative-stress-induced cell death in HT22 hippocampal neurons: involvement of Nrf2/HO-1 pathway. CNS Neurosci Ther 2014;20:840–50
212. M.F.Tolba, S.S.Azab, A.E.Khalifa,. Caffeic acid phenethyl ester, a promising component of propolis with a plethora of biological activities: a review on its anti-inflammatory, neuroprotective, hepatoprotective, and cardioprotective effects. IUBMB Life 2013;65:699–709
213. J.K.Kim, H.D.Jang Nrf2-mediated HO-1 induction coupled with the ERK signaling pathway contributes to indirect antioxidant capacity of caffeic acid phenethyl ester in HepG2 cells. Int J Mol Sci 2014;15:12149–65
214. Y.Lee, D.H.Shin, J.H.Kim,. Caffeic acid phenethyl ester-mediated Nrf2 activation and IkappaB kinase inhibition are involved in NFkappaB inhibitory effect: structural analysis for NFkappaB inhibition. Eur J Pharmacol 2010;643:21–8
215. H.Kim, W.Kim, S.Yum,. Caffeic acid phenethyl ester activation of Nrf2 pathway is enhanced under oxidative state: structural analysis and potential as a pathologically targeted therapeutic agent in treatment of colonic inflammation. Free Radic Biol Med 2013;65:552–62
216. T.Hu, X.W.He, J.G.Jiang, X.L.Xu Hydroxytyrosol and its potential therapeutic effects. J Agric Food Chem 2014;62:1449–55
217. M.A.Martín, S.Ramos, A.B.Granado-Serrano,. Hydroxytyrosol induces antioxidant/detoxificant enzymes and Nrf2 translocation via extracellular regulated kinases and phosphatidylinositol-3-kinase/protein kinase B pathways in HepG2 cells. Mol Nutr Food Res 2010;54:956–66
218. H.Zrelli, M.Matsuoka, S.Kitazaki,. Hydroxytyrosol induces proliferation and cytoprotection against oxidative injury in vascular endothelial cells: role of Nrf2 activation and HO-1 induction. J Agric Food Chem 2011;59:4473–82
219. H.Zrelli, M.Kusunoki, H.Miyazaki Role of hydroxytyrosol-dependent regulation of HO-1 expression in promoting wound healing of vascular endothelial cells via Nrf2 de novo synthesis and stabilization. Phytother Res 2015;29:1011–18
220. S.Schaffer, B.Halliwell Comment on hydroxytyrosol induces proliferation and cytoprotection against oxidative injury in vascular endothelial cells: role of Nrf2 activation and HO-1 induction. J Agric Food Chem 2011;59:10770–1
221. X.Zou, Z.Feng, Y.Li,. Stimulation of GSH synthesis to prevent oxidative stress-induced apoptosis by hydroxytyrosol in human retinal pigment epithelial cells: activation of Nrf2 and JNK-p62/SQSTM1 pathways. J Nutr Biochem 2012;23:994–1006
222. E.N.Story, R.E.Kopec, S.J.Schwartz, G.K.Harris An update on the health effects of tomato lycopene. Annu Rev Food Sci Technol 2010;1:189–210
223. A.Ben-Dor, M.Steiner, L.Gheber,. Carotenoids activate the antioxidant response element transcription system. Mol Cancer Ther 2005;4:177–86
224. Y.A.Goo, Z.Li, N.Pajkovic,. Systematic investigation of lycopene effects in LNCaP cells by use of novel large-scale proteomic analysis software. Proteomics Clin Appl 2007;1:513–23
225. F.Lian, X.D.Wang Enzymatic metabolites of lycopene induce Nrf2-mediated expression of phase II detoxifying/antioxidant enzymes in human bronchial epithelial cells. Int J Cancer 2008;123:1262–8
226. K.Sahin, C.Orhan, M.Tuzcu,. Orally administered lycopene attenuates diethylnitrosamine-induced hepatocarcinogenesis in rats by modulating Nrf-2/HO-1 and Akt/mTOR pathways. Nutr Cancer 2014;66:590–8
227. C.Dai, S.Tang, S.Deng,. Lycopene attenuates colistin-induced nephrotoxicity in mice via activation of the Nrf2/HO-1 pathway. Antimicrob Agents Chemother 2015;59:579–85
228. K.Sahin, M.Tuzcu, N.Sahin,. Nrf2/HO-1 signaling pathway may be the prime target for chemoprevention of cisplatin-induced nephrotoxicity by lycopene. Food Chem Toxicol 2010;48:2670–4
229. G.P.Nagaraju, S.F.Zafar, B.F.El-Rayes Pleiotropic effects of genistein in metabolic, inflammatory, and malignant diseases. Nutr Rev 2013;71:562–72
230. X.Zhai, M.Lin, F.Zhang,. Dietary flavonoid genistein induces Nrf2 and phase II detoxification gene expression via ERKs and PKC pathways and protects against oxidative stress in Caco-2 cells. Mol Nutr Food Res 2013;57:249–59
231. R.Wang, J.Tu, Q.Zhang,. Genistein attenuates ischemic oxidative damage and behavioral deficits via eNOS/Nrf2/HO-1 signaling. Hippocampus 2013;23:634–47
232. L.Lipińska, E.Klewicka, M.Sójka The structure, occurrence and biological activity of ellagitannins: a general review. Acta Sci Pol Technol Aliment 2014;13:289–99
233. Y.Ding, B.Zhang, K.Zhou,. Dietary ellagic acid improves oxidant-induced endothelial dysfunction and atherosclerosis: role of Nrf2 activation. Int J Cardiol 2014;175:508–14
234. T.Mrudula, P.Suryanarayana, P.Srinivas, G.B.Reddy Effect of curcumin on hyperglycemia-induced vascular endothelial growth factor expression in streptozotocin-induced diabetic rat retina. Biochem Biophys Res Commun 2007;361:528–32
235. R.A.Kowluru, M.Kanwar Effects of curcumin on retinal oxidative stress and inflammation in diabetes. Nutr Metab 2007;4:8
236. S.K.Gupta, B.Kumar, T.C.Nag,. Curcumin prevents experimental diabetic retinopathy in rats through its hypoglycemic, antioxidant, and anti-inflammatory mechanisms. J Ocul Pharmacol Ther 2011;27:123–30
237. R.Steigerwalt, M.Nebbioso, G.Appendino,. Meriva®, a lecithinized curcumin delivery system, in diabetic microangiopathy and retinopathy. Panminerva Med 2012;54:11
238. Z.F.Zuo, Q.Zhang, X.Z.Liu Protective effects of curcumin on retinal Müller cell in early diabetic rats. Int J Ophthalmol 2013;6:422
239. J.H.Kim, B.J.Lee, J.H.Kim,. Anti-angiogenic effect of caffeic acid on retinal neovascularization. Vascul Pharmacol 2009;51:262–7
240. P.Skopinski, J.Szaflik, B.Duda-Król,. Suppression of angiogenic activity of sera from diabetic patients with non-proliferative retinopathy by compounds of herbal origin and sulindac sulfone. Int J Mol Med 2004;14:707–18
241. K.C.Silva, M.A.Rosales, D.E.Hamassaki,. Green tea is neuroprotective in diabetic retinopathy. Invest Ophthalmol Vis Sci 2013;54:1325–36
242. H.Kim, J.S.Choi, K.S.Kim,. Flt1 peptide-hyaluronate conjugate micelle-like nanoparticles encapsulating genistein for the treatment of ocular neovascularization. Acta Biomater 2012;8:3932–40
243. A.S.Ibrahim, M.M.El-Shishtawy, A.PeñaJr, G.I.Liou Genistein attenuates retinal inflammation associated with diabetes by targeting of microglial activation. Mol Vis 2010;16:2033
244. H.Y.Oh, S.S.Kim, H.-Y.Chung, S.Yoon Isoflavone supplements exert hormonal and antioxidant effects in postmenopausal Korean women with diabetic retinopathy. J Med Food 2005;8:1–7
245. M.Nakajima, M.J.Cooney, A.H.Tu,. Normalization of retinal vascular permeability in experimental diabetes with genistein. Invest Ophthalmol Vis Sci 2001;42:2110–14
246. F.Ghadiri Soufi, E.Arbabi‐Aval, M.Rezaei Kanavi,. Anti-inflammatory properties of resveratrol in the retinas of type 2 diabetic rats. Clin Exp Pharmacol Physiol 2015;42:63–8
247. C.-M.Chan, H.-H.Chang, V.-C.Wang,. Inhibitory effects of resveratrol on PDGF-BB-induced retinal pigment epithelial cell migration via PDGFRβ, PI3K/Akt and MAPK pathways. PLoS One 2013;8:e56819
248. A.S.Yar, S.Menevse, I.Dogan,. Investigation of ocular neovascularization-related genes and oxidative stress in diabetic rat eye tissues after resveratrol treatment. J Med Food 2012;15:391–8
249. X.Q.Liu, B.J.Wu, W.H.Pan,. Resveratrol mitigates rat retinal ischemic injury: the roles of matrix metalloproteinase-9, inducible nitric oxide, and heme oxygenase-1. J Ocul Pharmacol Ther 2013;29:33–40
250. Y.H.Kim, Y.S.Kim, G.S.Roh,. Resveratrol blocks diabetes‐induced early vascular lesions and vascular endothelial growth factor induction in mouse retinas. Acta Ophthalmol 2012;90:e31–e7
251. J.N.Losso, R.E.Truax, G.Richard Trans-resveratrol inhibits hyperglycemia-induced inflammation and connexin downregulation in retinal pigment epithelial cells. J Agric Food Chem 2010;58:8246–52
252. B.Kumar, S.K.Gupta, T.C.Nag,. Retinal neuroprotective effects of quercetin in streptozotocin-induced diabetic rats. Exp Eye Res 2014;125:193–202
253. H.S.Lee, J.H.Jun, E.H.Jung,. Epigalloccatechin-3-gallate inhibits ocular neovascularization and vascular permeability in human retinal pigment epithelial and human retinal microvascular endothelial cells via suppression of MMP-9 and VEGF activation. Molecules 2014;19:12150–72